Researchers to discuss targeting GPCR networks as a proposed route to slower aging
A Frontiers webinar on 10 December 2026 will discuss a proposed network-level approach to GPCR signaling aimed at slowing aging.
A Frontiers webinar on 10 December 2026 will discuss a proposed network-level approach to GPCR signaling aimed at slowing aging.
A laboratory study in immortalized human chondrocytes reports that high concentrations of metformin trigger caspase- and ROS-dependent apoptosis in senescent ...
A review in Molecular Biology Reports examines how therapy-induced senescence and the SASP reshape the tumor immune microenvironment, and how ...
Deep inside nearly every cell, a molecular cleanup crew works around the clock to keep the interior tidy. One of ...
A new review proposes that the DNA damage response drives PD-L1 upregulation in senescent cells, enabling immune evasion and creating ...
A new review argues that the longevity enzyme sirtuin 1 sits at the molecular crossroads between cellular senescence and heart ...
An NYU Abu Dhabi study in EMBO Reports shows that a single cancer-causing gene drives liver cells into distinct senescent ...
New research shows that gamma irradiation drives p53 wild-type medulloblastoma cells into a senescent state that senolytic drugs such as ...
Researchers report that the mitochondria-targeting compound SMIP004 selectively kills therapy-induced senescent cancer cells by promoting degradation of the AMPK-stabilized metabolic ...
A nine-month study in mice shows that chronic senolytic treatment and aerobic exercise each reduce senescent cell markers in the ...
A phase-2 randomized trial shows intermittent dasatinib plus quercetin significantly improved liver fibrosis and resolved MASH in nearly half of ...
A new mouse study shows that senolytic drugs targeting senescent cells can partially mitigate the bone loss and marrow fat ...
A new review in Aging Cell positions endothelial TLR4 as a context-dependent molecular rheostat controlling vascular senescence, arguing that precision ...
Researchers engineered two fisetin-derived flavonoid analogs that kill senescent cells up to 27 times more potently than fisetin and reduce ...
A new letter in the Journal of Translational Medicine argues that a senolytic vaccine study showed real therapeutic benefit in ...
A new Nature Aging study from Albert Einstein College of Medicine shows that age-related decline in chaperone-mediated autophagy allows senescent ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.